With several high-profile manufacturing outlays already in the books in Europe this year, Sanofi is returning to the bloc in ...

They found that mRNA vaccines that target C. diff cells and the toxins they produce generated a lasting immune response in ...

ALS is an inventor on an international patent application, PCT/SG2023/050610, Title: Novel vaccine composition with improved protection efficacy. EEO has served in various advisory capacities on ...

Typhoid fever and paratyphoid fever: vaccination. Sanofi Pasteur. Package insert - Typhim Vi. Crucell Switzerland Ltd. Package insert - Vivotif. McNeil MM, DeStefano F. Vaccine-associated ...

If Donald Trump becomes president again, it looks like Robert F. Kennedy Jr. will have his say over who gets which vaccines: Trump said at a rally last weekend that he would let RFK Jr. “go wild ...

With flu season underway and new, developing COVID-19 strains, health professionals continue to stress the importance of receiving an updated vaccine. On Oct. 23, the Centers for Disease Control ...

We provide potentially life-changing treatment options and life-saving vaccine protection to millions of people ... i BEYFORTUS® Product Monograph, Sanofi Pasteur Limited, June 14, 2024. ii BEYFORTUS® ...

More information: Angela R Branche, Real-world effectiveness studies of the benefit of RSV vaccines, The Lancet (2024).DOI: 10.1016/S0140-6736(24)02150-0 Amanda B Payne et al, Respiratory ...

Vaccines are the original immunotherapy, in the view of Ryan Sullivan, a cancer immunotherapy researcher and oncologist at Mass General Cancer Center. But many other modes of immunotherapy for ...

RSV vaccines effective, but more people need to get them Date: October 28, 2024 Source: University of Rochester Medical Center Summary: Doctors detail what we learned after the first season ...

All growth rates mentioned below are on a year-on-year basis and at CER. Sanofi’s Biopharma segment includes Pharma and Vaccines. Biopharma sales rose 16.6% in the quarter to €12.17 billion. Pharma ...

Sanofi’s Biopharma segment includes Pharma and Vaccines. Biopharma sales rose 16.6% in the quarter to €12.17 billion. Pharma sales increased 13.0% in the quarter to €8.37 billion ...